Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops naturally occurring therapeutic antibodies from resilient individuals, has announced initiation of a Phase 1 first-in-human study of ATLX-1282.
Haughton Design, a UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as chief executive officer (CEO) to lead the company’s next phase of growth.
Bespak, a manufacturer of drug delivery systems, has reaffirmed its commitment to sustainable and responsible business by partnering with Tunley Environmental to complete their inaugural Supply Chain Biodiversity Footprint (SCBF) assessment.
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced plans to establish a new initiative to advance the safe adoption of agentic AI.
eXmoor Pharma, the integrated cell and gene therapy CDMO, has announced a new strategic partnership with Anthony Nolan: Cell Therapy & Laboratory Services (CT&LS).
One2Treat, a technology company transforming how the patient voice is integrated into clinical development, has announced the successful completion of a planned seed extension to accelerate its software platform development.
HERMA, a manufacturer of precision labelling machines for a variety of sectors, will showcase a quartet of high-performance labelling solutions at Pack Expo Las Vegas, 29th September - 1st October.
Aptamer Group has announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.
